Related Experiment Video
Updated: Jan 8, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
The value of functional genomics: a contingent valuation
Francisco Santos-Gonzalez1,2, Ellenore Martin2, Madeleine Harris2
1Economics of Genomics and Precision Medicine Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Parents and carers of individuals with rare diseases place significant monetary value on functional genomics testing. This willingness to pay highlights the perceived diagnostic utility of these advanced genomic approaches.
Area of Science:
- Genomics
- Rare Diseases
- Health Economics
Background:
- Genomic sequencing can be insufficient for diagnosing rare diseases.
- Functional genomics (transcriptomics, proteomics) offers alternative diagnostic insights.
- This study assesses the economic value of functional genomics for rare disease patients.
Purpose of the Study:
- To estimate the monetary value placed on functional genomics testing by patients and carers of rare diseases.
- To inform economic evaluations and clinical implementation decisions for functional genomics.
Main Methods:
- Contingent valuation survey (triple-bounded dichotomous choice) used.
- Participants included carers and individuals with suspected rare monogenic disorders.
- Multilevel interval regression analyzed willingness to pay (WTP).
Main Results:
- 57 respondents participated, mostly carers (95%).
- Mean WTP for functional genomics testing estimated at $2,522 (US $1,568).
- Confidence intervals provided for WTP estimates.
Conclusions:
- Individuals with undiagnosed rare diseases and their families highly value functional genomics.
- Estimated WTP exceeds the cost of proteomics testing.
- Findings support preference-based evaluations of functional genomics benefits.
Related Concept Videos
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Measurement of Bioavailability: Pharmacodynamic Methods
Biodiversity and Human Values

